
TSE:MFC
This summary was created by AI, based on 27 opinions in the last 12 months.
Manulife Financial (MFC-T) presents a mixed outlook among experts, with many pointing to its strong capital position, healthy growth in Asia, and attractive dividend yield as positives. Some analysts highlight a recent dip due to earnings concerns, yet the overall sentiment leans toward the belief that MFC is fundamentally sound, especially with its strategic initiatives in wealth management and the Asian market. However, there is caution about potential market volatility and the necessity for macroeconomic factors to shift positively for the stock to reach new heights. The company is seen as a reliable income stock rather than a growth play, with its valuation being reasonable in comparison to peers, although many believe it may be undervalued relative to its long-term potential.
Breaking out of a more than decade-long range. Finally have some fundamentals on LTC portfolio. Reinsurance deal was better than expected. Underlying business performing pretty well. Asia has both potential and potential risks. Not expensive. Have to see if the big institutional money moves in. Yield is 5.05%.
(Analysts’ price target is $31.11)It's popped slightly recently. They just did a deal in which they released $1.2 billion of free capital--this finally woke up people that MFC is a little undervalued. It still is at 8x PE with a price-to-book of 1.3x. Under this CEO in recent years, they've been streamlining operations to be more efficient and adding growth. This has been a top pick of his many times.
Growth continues to be limited. The shares have been rangebound between $20-30 for many years. Fundamentals are merely okay. Their footprint is mostly in Canada with an insurance business in the US, plus the Asian division and wealth management. The latter two businesses are doing well and enjoy growth, but Canada offers flat growth because insurance here is fully mature. The US is a slow grind. Trades around 8x PE, which is cheap vs. peers and banks. Problem is flat growth. The dividend pays 6% but so does a bond. This is a show-me story.
MFC is now trading at 7.3x times the forward P/E. In the 3Q, MFC’s core EPS grew 35% to $0.92, beating estimates of $0.81. Core ROE is also quite healthy around 16.8%. The adjusted book value per share grew 4% to $30.67. The balance sheet is healthy, with long-term debt of $13B and long-term debt/equity stands at 0.21x. Overall, a solid quarter for MFC MFC has also ramped up share buybacks in recent quarters, which we like. One of the reasons we like SLF over MFC is due to its track record. SLF is more conservative in the way they run their business. For example, SLF did not have to cut its dividend in the financial crisis of 2008, while MFC did. It has, simply, proven more reliable over the past two decades. It is a bit more expensive, but we think the premium is justified.
Unlock Premium - Try 5i Free
Ranks a bit higher than SLF on his screens, but it's not by a significant amount. Exposure to Asia, a growing market. Yield is 4.9%, dividend should increase over time.
Some of the insurers are outperforming the banks because they're a bit more levered to falling interest rates, fewer credit concerns and loan-loss provisions. Likes banks, too.